Patents by Inventor Bert M. Glaser

Bert M. Glaser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Internal limiting membrane rake
    Patent number: 7731728
    Abstract: A medical device for removing a thin membrane from the inner surface of an eye. The device comprises a rake that includes a handle having a hollow body from which a slide member telescopes. A plurality of tines are provided on a free end of the slide member, wherein each tine includes a tissue engaging feature provided on a free end of each tine. The tines are extended and retracted from an end of the handle, such that, when completely retracted, only the tissue engaging features protrude from the handle or all tissue engaging features can be retracted into the handle. In operation, the rake is manipulated along an upper surface of the membrane until the tissue engaging features engage the membrane. Once the tines engage the membrane, the rake is moved upward and tangentially away relative to an upper surface of the retina until the membrane is removed therefrom.
    Type: Grant
    Filed: April 14, 2005
    Date of Patent: June 8, 2010
    Inventor: Bert M. Glaser
  • Sampling Ocular Fluid
    Publication number: 20090318856
    Abstract: The present invention includes an ophthalmic aspirating device that allows the relatively non-invasive removal of small volumes of ocular fluid for diagnostic and other purposes. The invention also includes an ophthalmic aspirating device that allows the for the injection of materials into the eye at the time of aspiration. The invention further includes methods of aspirating ocular fluid from an eye using an ophthalmic aspirating device.
    Type: Application
    Filed: December 17, 2008
    Publication date: December 24, 2009
    Inventor: Bert M. Glaser
  • Method of treating ophthalmic disorders using TGF -.beta.
    Patent number: 5767079
    Abstract: This invention is a method for the treatment of ophthalmic disorders. The method is suitable for treatment of a variety of disorders including macular holes, macular degeneration, and retinal detachment and tears, cataracts, and corneal and scleral injuries. The method entails application of an effective amount of Transforming Growth Factor-.beta. (TGF-.beta.) to the affected region.
    Type: Grant
    Filed: August 27, 1996
    Date of Patent: June 16, 1998
    Assignee: Celtrix Pharmaceuticals, Inc.
    Inventors: Bert M. Glaser, Bruce B. Pharriss, deceased, Ann F. Hanham, George A. Ksander
  • Neovascularization inhibitors and methods for their production and use
    Patent number: 4996159
    Abstract: Neovascularization inhibitors are disclosed, which are purified polypeptides recovered from cultured cells, including retinal pigment epithelial cells and human fibroblast cells. The polypeptides may be used for the treatment of diseases in which new blood vessel formation plays a role, such as diabetic retinopathy, senile macular degeneration, tumor growth, and rheumatoid arthritis.
    Type: Grant
    Filed: January 26, 1990
    Date of Patent: February 26, 1991
    Assignee: The Johns Hopkins University
    Inventor: Bert M. Glaser